January 30, 2019
Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma
Read More
January 30, 2019
Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection
Read More
January 30, 2019
Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection
Read More
January 30, 2019
Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection
Read More
January 30, 2019
Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection
Read More
January 30, 2019
Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection
Read More
January 30, 2019
EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C
Read More
January 30, 2019
Post-Authorization Safety Study of GSK Biologicals’ Pandemic Influenza Vaccine (H1N1) in the United Kingdom
Read More
January 30, 2019
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer’s Disease
Read More
January 30, 2019
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer’s Disease Dementia
Read More
Load More
X